RenBio, Inc.
- | Biotech or pharma, therapeutic R&D
- | Medical device or technology
RenBio focuses on delivery of DNA therapeutics using its novel MYO Technology™ to enable sustained production of a range of antibodies and proteins targeting infectious diseases, inflammatory diseases, blood disorders, and metabolic disease. In addition to its internal development programs, RenBio also seeks to partner its proprietary technology.
Address
New YorkNew York
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}